Huons

Bio & Pharma Huons receives A grade in ESG evaluation

South Korea’s Huons Co. said on Tuesday that it received an A (excellent) grade in the 2024 ESG evaluation recently released by the Korea Inst...

Bio & Pharma Huons’ overseas market expansion leads to record-high sales

South Korea's Huons Group is continuing its record-breaking performance while expanding its influence in the global market.According to Huons Group ...

Bio & Pharma Huons’ 2% lidocaine gets approval from FDA

South Korean pharmaceutical firm, Huons Co., announced on Monday that it has secured another significant regulatory milestone in the US with the Foo...

Bio & Pharma Huons sees tripling of lidocaine vial output in 3 years

South Korea’s Huons Co., an anesthetics vial producer, aims to triple its lidocaine output from 2026, targeting the US market, where it fills ...

Bio & Pharma S.Korea's Huons gets approval to supply anesthetics to Canada

Huons Co., a South Korean pharmaceutical company, has announced plans to expand its presence in the North American market by offering two anesthetic...